Searching the RRID Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
Cellosaurus is database indexing available cell lines from various collections: American Type Culture Collection (ATCC), Bioresource Collection and Research Center, Taiwan (BCRC), Banco de Células do Rio de Janeiro (BCRJ), CellBank Australia (CBA), Collection of Cell Lines in Veterinary Medicine (CCLV), Cell Lines Service (CLS), Coriell, Drosophila Genomics Resource Center (DGRC), Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSMZ), European Bank for induced pluripotent Stem Cells (EBiSC), European Collection of Authenticated Cell Cultures (ECACC), Interlab Cell Line Collection (ICLC), Institute for Fermentation Osaka (IFO), Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna (IZSLER) biobank, Japanese Collection of Research Bioresources (JCRB) Cell Bank, Kunming Cell Bank of Type Culture Collection (KCB), Korean Cell Line Bank (KCLB), Millipore, National Cell Bank of Iran (NCBI_Iran), National Cancer Institute - Developmental Therapeutics Program (NCI-DTP), NINDS Human Cell and Data Repository (NHCDR), NIH AIDS Reagent Program (NIH-ARP), NISES, RIKEN Bioresource Center Cell Bank (RCB), Royan Stem Cell Bank (RSCB), Tick Cell Biobank (TCB), Tohoku University cell line catalog (TKG), and Ximbio.
| Name | Proper Citation | Organism | Disease |
Comments |
Defining Citation | Category | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MRC-5 Resource Report Resource Website 1000+ mentions Discontinued |
AddexBio Cat# T0016002/4922, RRID:CVCL_0440 | Homo sapiens (Human) | Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Senescence: Capable of attaining 42-46 population doublings before the onset of senescence (ATCC=CCL-171). Senesces at 26 PDL (PubMed=17395773)., Biotechnology: Used for the production of the live zoster vaccine (Trade name: Zostavax)., Biotechnology: Used for the production of the live varicella virus vaccine (Trade name: Varivax)., Biotechnology: Used for the production of the Hepatitis A vaccines Avaxim, Epaxal, Havrix and Vaqta., Biotechnology: Used for the production of the Human Diploid Cell Vaccine (HDCV) against rabies (Trade name: Imovax Rabies)., Group: Vaccine production cell line. |
PMID:113411 PMID:211143 PMID:932048 PMID:1031681 PMID:1193162 PMID:1756776 PMID:1965304 PMID:3335022 PMID:4316953 PMID:6538202 PMID:6971834 PMID:7065527 PMID:10752125 PMID:11416159 PMID:17395773 PMID:19657000 PMID:21637780 PMID:25877200 PMID:25903999 PMID:26477663 PMID:31869419 PMID:33389257 |
Finite cell line | Male | MRC5, MRC 5, MRCV, MRC-V, Medical Research Council cell strain-5 | AddexBio | T0016002/4922 | BTO:BTO_0001590, CLO:CLO_0007865, CLO:CLO_0050055, EFO:EFO_0002835, MCCL:MCC:0000336, CLDB:cl3563, CLDB:cl3564, CLDB:cl3566, CLDB:cl3567, CLDB:cl3568, CLDB:cl5168, AddexBio:T0016002/4922, ATCC:CCL-171, BCRC:60023, BCRJ:0180, BioSample:SAMN01821580, BioSample:SAMN01821702, BioSample:SAMN01821735, BioSample:SAMN03473183, CCRID:1101HUM-PUMC000044, CCRID:1102HUM-NIFDC00002, CCRID:3101HUMGNHu41, CCRID:3101HUMSCSP5040, CCRID:4201HUM-CCTCC00032, CCRID:5301HUM-KCB89023YJ, CCTCC:GDC0032, ChEMBL-Cells:CHEMBL3308499, ChEMBL-Targets:CHEMBL614181, CLS:300395, ECACC:97112601, FCS-free:179-2-338-1-16-3, GEO:GSM248209, GEO:GSM248210, GEO:GSM520665, GEO:GSM520666, GEO:GSM520667, GEO:GSM579888, GEO:GSM579889, GEO:GSM607969, GEO:GSM3738752, GEO:GSM3738753, IBRC:C10313, ICLC:HL95001, IZSLER:BS CL 68, JCRB:IFO50073, JCRB:JCRB9008, KCB:KCB 200412YJ, KCB:KCB 89023YJ, KCLB:10171, Lonza:52, NCBI_Iran:C125, PRIDE:PXD001909, PRIDE:PXD013120, PRIDE:PXD023286, PubChem_Cell_line:CVCL_0440, RCB:RCB0211, RCB:RCB0218, Wikidata:Q3273166 |
CVCL_0440 | 2026-08-01 05:23:45 | 2853 | |||
|
MRC-5 Resource Report Resource Website 1000+ mentions Discontinued |
JCRB Cat# IFO50073, RRID:CVCL_0440 | Homo sapiens (Human) | Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Senescence: Capable of attaining 42-46 population doublings before the onset of senescence (ATCC=CCL-171). Senesces at 26 PDL (PubMed=17395773)., Biotechnology: Used for the production of the live zoster vaccine (Trade name: Zostavax)., Biotechnology: Used for the production of the live varicella virus vaccine (Trade name: Varivax)., Biotechnology: Used for the production of the Hepatitis A vaccines Avaxim, Epaxal, Havrix and Vaqta., Biotechnology: Used for the production of the Human Diploid Cell Vaccine (HDCV) against rabies (Trade name: Imovax Rabies)., Group: Vaccine production cell line. |
PMID:113411 PMID:211143 PMID:932048 PMID:1031681 PMID:1193162 PMID:1756776 PMID:1965304 PMID:3335022 PMID:4316953 PMID:6538202 PMID:6971834 PMID:7065527 PMID:10752125 PMID:11416159 PMID:17395773 PMID:19657000 PMID:21637780 PMID:25877200 PMID:25903999 PMID:26477663 PMID:31869419 PMID:33389257 |
Finite cell line | Male | MRC5, MRC 5, MRCV, MRC-V, Medical Research Council cell strain-5 | JCRB | IFO50073 | BTO:BTO_0001590, CLO:CLO_0007865, CLO:CLO_0050055, EFO:EFO_0002835, MCCL:MCC:0000336, CLDB:cl3563, CLDB:cl3564, CLDB:cl3566, CLDB:cl3567, CLDB:cl3568, CLDB:cl5168, AddexBio:T0016002/4922, ATCC:CCL-171, BCRC:60023, BCRJ:0180, BioSample:SAMN01821580, BioSample:SAMN01821702, BioSample:SAMN01821735, BioSample:SAMN03473183, CCRID:1101HUM-PUMC000044, CCRID:1102HUM-NIFDC00002, CCRID:3101HUMGNHu41, CCRID:3101HUMSCSP5040, CCRID:4201HUM-CCTCC00032, CCRID:5301HUM-KCB89023YJ, CCTCC:GDC0032, ChEMBL-Cells:CHEMBL3308499, ChEMBL-Targets:CHEMBL614181, CLS:300395, ECACC:97112601, FCS-free:179-2-338-1-16-3, GEO:GSM248209, GEO:GSM248210, GEO:GSM520665, GEO:GSM520666, GEO:GSM520667, GEO:GSM579888, GEO:GSM579889, GEO:GSM607969, GEO:GSM3738752, GEO:GSM3738753, IBRC:C10313, ICLC:HL95001, IZSLER:BS CL 68, JCRB:IFO50073, JCRB:JCRB9008, KCB:KCB 200412YJ, KCB:KCB 89023YJ, KCLB:10171, Lonza:52, NCBI_Iran:C125, PRIDE:PXD001909, PRIDE:PXD013120, PRIDE:PXD023286, PubChem_Cell_line:CVCL_0440, RCB:RCB0211, RCB:RCB0218, Wikidata:Q3273166 |
CVCL_0440 | 2026-08-01 05:23:45 | 2853 | |||
|
MRC-5 Resource Report Resource Website 1000+ mentions Discontinued |
JCRB Cat# JCRB9008, RRID:CVCL_0440 | Homo sapiens (Human) | Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Senescence: Capable of attaining 42-46 population doublings before the onset of senescence (ATCC=CCL-171). Senesces at 26 PDL (PubMed=17395773)., Biotechnology: Used for the production of the live zoster vaccine (Trade name: Zostavax)., Biotechnology: Used for the production of the live varicella virus vaccine (Trade name: Varivax)., Biotechnology: Used for the production of the Hepatitis A vaccines Avaxim, Epaxal, Havrix and Vaqta., Biotechnology: Used for the production of the Human Diploid Cell Vaccine (HDCV) against rabies (Trade name: Imovax Rabies)., Group: Vaccine production cell line. |
PMID:113411 PMID:211143 PMID:932048 PMID:1031681 PMID:1193162 PMID:1756776 PMID:1965304 PMID:3335022 PMID:4316953 PMID:6538202 PMID:6971834 PMID:7065527 PMID:10752125 PMID:11416159 PMID:17395773 PMID:19657000 PMID:21637780 PMID:25877200 PMID:25903999 PMID:26477663 PMID:31869419 PMID:33389257 |
Finite cell line | Male | MRC5, MRC 5, MRCV, MRC-V, Medical Research Council cell strain-5 | JCRB | JCRB9008 | BTO:BTO_0001590, CLO:CLO_0007865, CLO:CLO_0050055, EFO:EFO_0002835, MCCL:MCC:0000336, CLDB:cl3563, CLDB:cl3564, CLDB:cl3566, CLDB:cl3567, CLDB:cl3568, CLDB:cl5168, AddexBio:T0016002/4922, ATCC:CCL-171, BCRC:60023, BCRJ:0180, BioSample:SAMN01821580, BioSample:SAMN01821702, BioSample:SAMN01821735, BioSample:SAMN03473183, CCRID:1101HUM-PUMC000044, CCRID:1102HUM-NIFDC00002, CCRID:3101HUMGNHu41, CCRID:3101HUMSCSP5040, CCRID:4201HUM-CCTCC00032, CCRID:5301HUM-KCB89023YJ, CCTCC:GDC0032, ChEMBL-Cells:CHEMBL3308499, ChEMBL-Targets:CHEMBL614181, CLS:300395, ECACC:97112601, FCS-free:179-2-338-1-16-3, GEO:GSM248209, GEO:GSM248210, GEO:GSM520665, GEO:GSM520666, GEO:GSM520667, GEO:GSM579888, GEO:GSM579889, GEO:GSM607969, GEO:GSM3738752, GEO:GSM3738753, IBRC:C10313, ICLC:HL95001, IZSLER:BS CL 68, JCRB:IFO50073, JCRB:JCRB9008, KCB:KCB 200412YJ, KCB:KCB 89023YJ, KCLB:10171, Lonza:52, NCBI_Iran:C125, PRIDE:PXD001909, PRIDE:PXD013120, PRIDE:PXD023286, PubChem_Cell_line:CVCL_0440, RCB:RCB0211, RCB:RCB0218, Wikidata:Q3273166 |
CVCL_0440 | 2026-08-01 05:23:40 | 2853 | |||
|
MRC-5 Resource Report Resource Website 1000+ mentions Discontinued |
CCTCC Cat# GDC0032, RRID:CVCL_0440 | Homo sapiens (Human) | Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Senescence: Capable of attaining 42-46 population doublings before the onset of senescence (ATCC=CCL-171). Senesces at 26 PDL (PubMed=17395773)., Biotechnology: Used for the production of the live zoster vaccine (Trade name: Zostavax)., Biotechnology: Used for the production of the live varicella virus vaccine (Trade name: Varivax)., Biotechnology: Used for the production of the Hepatitis A vaccines Avaxim, Epaxal, Havrix and Vaqta., Biotechnology: Used for the production of the Human Diploid Cell Vaccine (HDCV) against rabies (Trade name: Imovax Rabies)., Group: Vaccine production cell line. |
PMID:113411 PMID:211143 PMID:932048 PMID:1031681 PMID:1193162 PMID:1756776 PMID:1965304 PMID:3335022 PMID:4316953 PMID:6538202 PMID:6971834 PMID:7065527 PMID:10752125 PMID:11416159 PMID:17395773 PMID:19657000 PMID:21637780 PMID:25877200 PMID:25903999 PMID:26477663 PMID:31869419 PMID:33389257 |
Finite cell line | Male | MRC5, MRC 5, MRCV, MRC-V, Medical Research Council cell strain-5 | CCTCC | GDC0032 | BTO:BTO_0001590, CLO:CLO_0007865, CLO:CLO_0050055, EFO:EFO_0002835, MCCL:MCC:0000336, CLDB:cl3563, CLDB:cl3564, CLDB:cl3566, CLDB:cl3567, CLDB:cl3568, CLDB:cl5168, AddexBio:T0016002/4922, ATCC:CCL-171, BCRC:60023, BCRJ:0180, BioSample:SAMN01821580, BioSample:SAMN01821702, BioSample:SAMN01821735, BioSample:SAMN03473183, CCRID:1101HUM-PUMC000044, CCRID:1102HUM-NIFDC00002, CCRID:3101HUMGNHu41, CCRID:3101HUMSCSP5040, CCRID:4201HUM-CCTCC00032, CCRID:5301HUM-KCB89023YJ, CCTCC:GDC0032, ChEMBL-Cells:CHEMBL3308499, ChEMBL-Targets:CHEMBL614181, CLS:300395, ECACC:97112601, FCS-free:179-2-338-1-16-3, GEO:GSM248209, GEO:GSM248210, GEO:GSM520665, GEO:GSM520666, GEO:GSM520667, GEO:GSM579888, GEO:GSM579889, GEO:GSM607969, GEO:GSM3738752, GEO:GSM3738753, IBRC:C10313, ICLC:HL95001, IZSLER:BS CL 68, JCRB:IFO50073, JCRB:JCRB9008, KCB:KCB 200412YJ, KCB:KCB 89023YJ, KCLB:10171, Lonza:52, NCBI_Iran:C125, PRIDE:PXD001909, PRIDE:PXD013120, PRIDE:PXD023286, PubChem_Cell_line:CVCL_0440, RCB:RCB0211, RCB:RCB0218, Wikidata:Q3273166 |
CVCL_0440 | 2026-08-01 05:23:40 | 2853 | |||
|
MRC-5 Resource Report Resource Website 1000+ mentions Discontinued |
NCBI_Iran Cat# C125, RRID:CVCL_0440 | Homo sapiens (Human) | Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Senescence: Capable of attaining 42-46 population doublings before the onset of senescence (ATCC=CCL-171). Senesces at 26 PDL (PubMed=17395773)., Biotechnology: Used for the production of the live zoster vaccine (Trade name: Zostavax)., Biotechnology: Used for the production of the live varicella virus vaccine (Trade name: Varivax)., Biotechnology: Used for the production of the Hepatitis A vaccines Avaxim, Epaxal, Havrix and Vaqta., Biotechnology: Used for the production of the Human Diploid Cell Vaccine (HDCV) against rabies (Trade name: Imovax Rabies)., Group: Vaccine production cell line. |
PMID:113411 PMID:211143 PMID:932048 PMID:1031681 PMID:1193162 PMID:1756776 PMID:1965304 PMID:3335022 PMID:4316953 PMID:6538202 PMID:6971834 PMID:7065527 PMID:10752125 PMID:11416159 PMID:17395773 PMID:19657000 PMID:21637780 PMID:25877200 PMID:25903999 PMID:26477663 PMID:31869419 PMID:33389257 |
Finite cell line | Male | MRC5, MRC 5, MRCV, MRC-V, Medical Research Council cell strain-5 | NCBI_Iran | C125 | BTO:BTO_0001590, CLO:CLO_0007865, CLO:CLO_0050055, EFO:EFO_0002835, MCCL:MCC:0000336, CLDB:cl3563, CLDB:cl3564, CLDB:cl3566, CLDB:cl3567, CLDB:cl3568, CLDB:cl5168, AddexBio:T0016002/4922, ATCC:CCL-171, BCRC:60023, BCRJ:0180, BioSample:SAMN01821580, BioSample:SAMN01821702, BioSample:SAMN01821735, BioSample:SAMN03473183, CCRID:1101HUM-PUMC000044, CCRID:1102HUM-NIFDC00002, CCRID:3101HUMGNHu41, CCRID:3101HUMSCSP5040, CCRID:4201HUM-CCTCC00032, CCRID:5301HUM-KCB89023YJ, CCTCC:GDC0032, ChEMBL-Cells:CHEMBL3308499, ChEMBL-Targets:CHEMBL614181, CLS:300395, ECACC:97112601, FCS-free:179-2-338-1-16-3, GEO:GSM248209, GEO:GSM248210, GEO:GSM520665, GEO:GSM520666, GEO:GSM520667, GEO:GSM579888, GEO:GSM579889, GEO:GSM607969, GEO:GSM3738752, GEO:GSM3738753, IBRC:C10313, ICLC:HL95001, IZSLER:BS CL 68, JCRB:IFO50073, JCRB:JCRB9008, KCB:KCB 200412YJ, KCB:KCB 89023YJ, KCLB:10171, Lonza:52, NCBI_Iran:C125, PRIDE:PXD001909, PRIDE:PXD013120, PRIDE:PXD023286, PubChem_Cell_line:CVCL_0440, RCB:RCB0211, RCB:RCB0218, Wikidata:Q3273166 |
CVCL_0440 | 2026-08-01 05:23:45 | 2853 | |||
|
MRC-5 Resource Report Resource Website 1000+ mentions Discontinued |
KCB Cat# KCB 200412YJ, RRID:CVCL_0440 | Homo sapiens (Human) | Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Senescence: Capable of attaining 42-46 population doublings before the onset of senescence (ATCC=CCL-171). Senesces at 26 PDL (PubMed=17395773)., Biotechnology: Used for the production of the live zoster vaccine (Trade name: Zostavax)., Biotechnology: Used for the production of the live varicella virus vaccine (Trade name: Varivax)., Biotechnology: Used for the production of the Hepatitis A vaccines Avaxim, Epaxal, Havrix and Vaqta., Biotechnology: Used for the production of the Human Diploid Cell Vaccine (HDCV) against rabies (Trade name: Imovax Rabies)., Group: Vaccine production cell line. |
PMID:113411 PMID:211143 PMID:932048 PMID:1031681 PMID:1193162 PMID:1756776 PMID:1965304 PMID:3335022 PMID:4316953 PMID:6538202 PMID:6971834 PMID:7065527 PMID:10752125 PMID:11416159 PMID:17395773 PMID:19657000 PMID:21637780 PMID:25877200 PMID:25903999 PMID:26477663 PMID:31869419 PMID:33389257 |
Finite cell line | Male | MRC5, MRC 5, MRCV, MRC-V, Medical Research Council cell strain-5 | KCB | KCB 200412YJ | BTO:BTO_0001590, CLO:CLO_0007865, CLO:CLO_0050055, EFO:EFO_0002835, MCCL:MCC:0000336, CLDB:cl3563, CLDB:cl3564, CLDB:cl3566, CLDB:cl3567, CLDB:cl3568, CLDB:cl5168, AddexBio:T0016002/4922, ATCC:CCL-171, BCRC:60023, BCRJ:0180, BioSample:SAMN01821580, BioSample:SAMN01821702, BioSample:SAMN01821735, BioSample:SAMN03473183, CCRID:1101HUM-PUMC000044, CCRID:1102HUM-NIFDC00002, CCRID:3101HUMGNHu41, CCRID:3101HUMSCSP5040, CCRID:4201HUM-CCTCC00032, CCRID:5301HUM-KCB89023YJ, CCTCC:GDC0032, ChEMBL-Cells:CHEMBL3308499, ChEMBL-Targets:CHEMBL614181, CLS:300395, ECACC:97112601, FCS-free:179-2-338-1-16-3, GEO:GSM248209, GEO:GSM248210, GEO:GSM520665, GEO:GSM520666, GEO:GSM520667, GEO:GSM579888, GEO:GSM579889, GEO:GSM607969, GEO:GSM3738752, GEO:GSM3738753, IBRC:C10313, ICLC:HL95001, IZSLER:BS CL 68, JCRB:IFO50073, JCRB:JCRB9008, KCB:KCB 200412YJ, KCB:KCB 89023YJ, KCLB:10171, Lonza:52, NCBI_Iran:C125, PRIDE:PXD001909, PRIDE:PXD013120, PRIDE:PXD023286, PubChem_Cell_line:CVCL_0440, RCB:RCB0211, RCB:RCB0218, Wikidata:Q3273166 |
CVCL_0440 | 2026-08-01 05:23:45 | 2853 | |||
|
MRC-5 Resource Report Resource Website 1000+ mentions Discontinued |
KCB Cat# KCB 89023YJ, RRID:CVCL_0440 | Homo sapiens (Human) | Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Senescence: Capable of attaining 42-46 population doublings before the onset of senescence (ATCC=CCL-171). Senesces at 26 PDL (PubMed=17395773)., Biotechnology: Used for the production of the live zoster vaccine (Trade name: Zostavax)., Biotechnology: Used for the production of the live varicella virus vaccine (Trade name: Varivax)., Biotechnology: Used for the production of the Hepatitis A vaccines Avaxim, Epaxal, Havrix and Vaqta., Biotechnology: Used for the production of the Human Diploid Cell Vaccine (HDCV) against rabies (Trade name: Imovax Rabies)., Group: Vaccine production cell line. |
PMID:113411 PMID:211143 PMID:932048 PMID:1031681 PMID:1193162 PMID:1756776 PMID:1965304 PMID:3335022 PMID:4316953 PMID:6538202 PMID:6971834 PMID:7065527 PMID:10752125 PMID:11416159 PMID:17395773 PMID:19657000 PMID:21637780 PMID:25877200 PMID:25903999 PMID:26477663 PMID:31869419 PMID:33389257 |
Finite cell line | Male | MRC5, MRC 5, MRCV, MRC-V, Medical Research Council cell strain-5 | KCB | KCB 89023YJ | BTO:BTO_0001590, CLO:CLO_0007865, CLO:CLO_0050055, EFO:EFO_0002835, MCCL:MCC:0000336, CLDB:cl3563, CLDB:cl3564, CLDB:cl3566, CLDB:cl3567, CLDB:cl3568, CLDB:cl5168, AddexBio:T0016002/4922, ATCC:CCL-171, BCRC:60023, BCRJ:0180, BioSample:SAMN01821580, BioSample:SAMN01821702, BioSample:SAMN01821735, BioSample:SAMN03473183, CCRID:1101HUM-PUMC000044, CCRID:1102HUM-NIFDC00002, CCRID:3101HUMGNHu41, CCRID:3101HUMSCSP5040, CCRID:4201HUM-CCTCC00032, CCRID:5301HUM-KCB89023YJ, CCTCC:GDC0032, ChEMBL-Cells:CHEMBL3308499, ChEMBL-Targets:CHEMBL614181, CLS:300395, ECACC:97112601, FCS-free:179-2-338-1-16-3, GEO:GSM248209, GEO:GSM248210, GEO:GSM520665, GEO:GSM520666, GEO:GSM520667, GEO:GSM579888, GEO:GSM579889, GEO:GSM607969, GEO:GSM3738752, GEO:GSM3738753, IBRC:C10313, ICLC:HL95001, IZSLER:BS CL 68, JCRB:IFO50073, JCRB:JCRB9008, KCB:KCB 200412YJ, KCB:KCB 89023YJ, KCLB:10171, Lonza:52, NCBI_Iran:C125, PRIDE:PXD001909, PRIDE:PXD013120, PRIDE:PXD023286, PubChem_Cell_line:CVCL_0440, RCB:RCB0211, RCB:RCB0218, Wikidata:Q3273166 |
CVCL_0440 | 2026-08-01 05:23:45 | 2853 | |||
|
MRC-5 Resource Report Resource Website 1000+ mentions Discontinued |
IBRC Cat# C10313, RRID:CVCL_0440 | Homo sapiens (Human) | Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Senescence: Capable of attaining 42-46 population doublings before the onset of senescence (ATCC=CCL-171). Senesces at 26 PDL (PubMed=17395773)., Biotechnology: Used for the production of the live zoster vaccine (Trade name: Zostavax)., Biotechnology: Used for the production of the live varicella virus vaccine (Trade name: Varivax)., Biotechnology: Used for the production of the Hepatitis A vaccines Avaxim, Epaxal, Havrix and Vaqta., Biotechnology: Used for the production of the Human Diploid Cell Vaccine (HDCV) against rabies (Trade name: Imovax Rabies)., Group: Vaccine production cell line. |
PMID:113411 PMID:211143 PMID:932048 PMID:1031681 PMID:1193162 PMID:1756776 PMID:1965304 PMID:3335022 PMID:4316953 PMID:6538202 PMID:6971834 PMID:7065527 PMID:10752125 PMID:11416159 PMID:17395773 PMID:19657000 PMID:21637780 PMID:25877200 PMID:25903999 PMID:26477663 PMID:31869419 PMID:33389257 |
Finite cell line | Male | MRC5, MRC 5, MRCV, MRC-V, Medical Research Council cell strain-5 | IBRC | C10313 | BTO:BTO_0001590, CLO:CLO_0007865, CLO:CLO_0050055, EFO:EFO_0002835, MCCL:MCC:0000336, CLDB:cl3563, CLDB:cl3564, CLDB:cl3566, CLDB:cl3567, CLDB:cl3568, CLDB:cl5168, AddexBio:T0016002/4922, ATCC:CCL-171, BCRC:60023, BCRJ:0180, BioSample:SAMN01821580, BioSample:SAMN01821702, BioSample:SAMN01821735, BioSample:SAMN03473183, CCRID:1101HUM-PUMC000044, CCRID:1102HUM-NIFDC00002, CCRID:3101HUMGNHu41, CCRID:3101HUMSCSP5040, CCRID:4201HUM-CCTCC00032, CCRID:5301HUM-KCB89023YJ, CCTCC:GDC0032, ChEMBL-Cells:CHEMBL3308499, ChEMBL-Targets:CHEMBL614181, CLS:300395, ECACC:97112601, FCS-free:179-2-338-1-16-3, GEO:GSM248209, GEO:GSM248210, GEO:GSM520665, GEO:GSM520666, GEO:GSM520667, GEO:GSM579888, GEO:GSM579889, GEO:GSM607969, GEO:GSM3738752, GEO:GSM3738753, IBRC:C10313, ICLC:HL95001, IZSLER:BS CL 68, JCRB:IFO50073, JCRB:JCRB9008, KCB:KCB 200412YJ, KCB:KCB 89023YJ, KCLB:10171, Lonza:52, NCBI_Iran:C125, PRIDE:PXD001909, PRIDE:PXD013120, PRIDE:PXD023286, PubChem_Cell_line:CVCL_0440, RCB:RCB0211, RCB:RCB0218, Wikidata:Q3273166 |
CVCL_0440 | 2026-08-01 05:23:45 | 2853 | |||
|
MRC-5 Resource Report Resource Website 1000+ mentions Discontinued |
RRID:CVCL_0440 | Homo sapiens (Human) | Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Senescence: Capable of attaining 42-46 population doublings before the onset of senescence (ATCC=CCL-171). Senesces at 26 PDL (PubMed=17395773)., Biotechnology: Used for the production of the live zoster vaccine (Trade name: Zostavax)., Biotechnology: Used for the production of the live varicella virus vaccine (Trade name: Varivax)., Biotechnology: Used for the production of the Hepatitis A vaccines Avaxim, Epaxal, Havrix and Vaqta., Biotechnology: Used for the production of the Human Diploid Cell Vaccine (HDCV) against rabies (Trade name: Imovax Rabies)., Group: Vaccine production cell line. |
PMID:113411 PMID:211143 PMID:932048 PMID:1031681 PMID:1193162 PMID:1756776 PMID:1965304 PMID:3335022 PMID:4316953 PMID:6538202 PMID:6971834 PMID:7065527 PMID:10752125 PMID:11416159 PMID:17395773 PMID:19657000 PMID:21637780 PMID:25877200 PMID:25903999 PMID:26477663 PMID:31869419 PMID:33389257 |
Finite cell line | Male | MRC5, MRC 5, MRCV, MRC-V, Medical Research Council cell strain-5 | BTO:BTO_0001590, CLO:CLO_0007865, CLO:CLO_0050055, EFO:EFO_0002835, MCCL:MCC:0000336, CLDB:cl3563, CLDB:cl3564, CLDB:cl3566, CLDB:cl3567, CLDB:cl3568, CLDB:cl5168, AddexBio:T0016002/4922, ATCC:CCL-171, BCRC:60023, BCRJ:0180, BioSample:SAMN01821580, BioSample:SAMN01821702, BioSample:SAMN01821735, BioSample:SAMN03473183, CCRID:1101HUM-PUMC000044, CCRID:1102HUM-NIFDC00002, CCRID:3101HUMGNHu41, CCRID:3101HUMSCSP5040, CCRID:4201HUM-CCTCC00032, CCRID:5301HUM-KCB89023YJ, CCTCC:GDC0032, ChEMBL-Cells:CHEMBL3308499, ChEMBL-Targets:CHEMBL614181, CLS:300395, ECACC:97112601, FCS-free:179-2-338-1-16-3, GEO:GSM248209, GEO:GSM248210, GEO:GSM520665, GEO:GSM520666, GEO:GSM520667, GEO:GSM579888, GEO:GSM579889, GEO:GSM607969, GEO:GSM3738752, GEO:GSM3738753, IBRC:C10313, ICLC:HL95001, IZSLER:BS CL 68, JCRB:IFO50073, JCRB:JCRB9008, KCB:KCB 200412YJ, KCB:KCB 89023YJ, KCLB:10171, Lonza:52, NCBI_Iran:C125, PRIDE:PXD001909, PRIDE:PXD013120, PRIDE:PXD023286, PubChem_Cell_line:CVCL_0440, RCB:RCB0211, RCB:RCB0218, Wikidata:Q3273166 |
CVCL_0440 | 2026-08-01 05:23:45 | 2853 | |||||
|
MRC-5 Resource Report Resource Website 1000+ mentions Discontinued |
ECACC Cat# 97112601, RRID:CVCL_0440 | Homo sapiens (Human) | Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Senescence: Capable of attaining 42-46 population doublings before the onset of senescence (ATCC=CCL-171). Senesces at 26 PDL (PubMed=17395773)., Biotechnology: Used for the production of the live zoster vaccine (Trade name: Zostavax)., Biotechnology: Used for the production of the live varicella virus vaccine (Trade name: Varivax)., Biotechnology: Used for the production of the Hepatitis A vaccines Avaxim, Epaxal, Havrix and Vaqta., Biotechnology: Used for the production of the Human Diploid Cell Vaccine (HDCV) against rabies (Trade name: Imovax Rabies)., Group: Vaccine production cell line. |
PMID:113411 PMID:211143 PMID:932048 PMID:1031681 PMID:1193162 PMID:1756776 PMID:1965304 PMID:3335022 PMID:4316953 PMID:6538202 PMID:6971834 PMID:7065527 PMID:10752125 PMID:11416159 PMID:17395773 PMID:19657000 PMID:21637780 PMID:25877200 PMID:25903999 PMID:26477663 PMID:31869419 PMID:33389257 |
Finite cell line | Male | MRC5, MRC 5, MRCV, MRC-V, Medical Research Council cell strain-5 | ECACC | 97112601 | BTO:BTO_0001590, CLO:CLO_0007865, CLO:CLO_0050055, EFO:EFO_0002835, MCCL:MCC:0000336, CLDB:cl3563, CLDB:cl3564, CLDB:cl3566, CLDB:cl3567, CLDB:cl3568, CLDB:cl5168, AddexBio:T0016002/4922, ATCC:CCL-171, BCRC:60023, BCRJ:0180, BioSample:SAMN01821580, BioSample:SAMN01821702, BioSample:SAMN01821735, BioSample:SAMN03473183, CCRID:1101HUM-PUMC000044, CCRID:1102HUM-NIFDC00002, CCRID:3101HUMGNHu41, CCRID:3101HUMSCSP5040, CCRID:4201HUM-CCTCC00032, CCRID:5301HUM-KCB89023YJ, CCTCC:GDC0032, ChEMBL-Cells:CHEMBL3308499, ChEMBL-Targets:CHEMBL614181, CLS:300395, ECACC:97112601, FCS-free:179-2-338-1-16-3, GEO:GSM248209, GEO:GSM248210, GEO:GSM520665, GEO:GSM520666, GEO:GSM520667, GEO:GSM579888, GEO:GSM579889, GEO:GSM607969, GEO:GSM3738752, GEO:GSM3738753, IBRC:C10313, ICLC:HL95001, IZSLER:BS CL 68, JCRB:IFO50073, JCRB:JCRB9008, KCB:KCB 200412YJ, KCB:KCB 89023YJ, KCLB:10171, Lonza:52, NCBI_Iran:C125, PRIDE:PXD001909, PRIDE:PXD013120, PRIDE:PXD023286, PubChem_Cell_line:CVCL_0440, RCB:RCB0211, RCB:RCB0218, Wikidata:Q3273166 |
CVCL_0440 | 2026-08-01 05:23:45 | 2853 | |||
|
MRC-5 Resource Report Resource Website 1000+ mentions Discontinued |
ATCC Cat# CCL-171, RRID:CVCL_0440 | Homo sapiens (Human) | Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Senescence: Capable of attaining 42-46 population doublings before the onset of senescence (ATCC=CCL-171). Senesces at 26 PDL (PubMed=17395773)., Biotechnology: Used for the production of the live zoster vaccine (Trade name: Zostavax)., Biotechnology: Used for the production of the live varicella virus vaccine (Trade name: Varivax)., Biotechnology: Used for the production of the Hepatitis A vaccines Avaxim, Epaxal, Havrix and Vaqta., Biotechnology: Used for the production of the Human Diploid Cell Vaccine (HDCV) against rabies (Trade name: Imovax Rabies)., Group: Vaccine production cell line. |
PMID:113411 PMID:211143 PMID:932048 PMID:1031681 PMID:1193162 PMID:1756776 PMID:1965304 PMID:3335022 PMID:4316953 PMID:6538202 PMID:6971834 PMID:7065527 PMID:10752125 PMID:11416159 PMID:17395773 PMID:19657000 PMID:21637780 PMID:25877200 PMID:25903999 PMID:26477663 PMID:31869419 PMID:33389257 |
Finite cell line | Male | MRC5, MRC 5, MRCV, MRC-V, Medical Research Council cell strain-5 | ATCC | CCL-171 | BTO:BTO_0001590, CLO:CLO_0007865, CLO:CLO_0050055, EFO:EFO_0002835, MCCL:MCC:0000336, CLDB:cl3563, CLDB:cl3564, CLDB:cl3566, CLDB:cl3567, CLDB:cl3568, CLDB:cl5168, AddexBio:T0016002/4922, ATCC:CCL-171, BCRC:60023, BCRJ:0180, BioSample:SAMN01821580, BioSample:SAMN01821702, BioSample:SAMN01821735, BioSample:SAMN03473183, CCRID:1101HUM-PUMC000044, CCRID:1102HUM-NIFDC00002, CCRID:3101HUMGNHu41, CCRID:3101HUMSCSP5040, CCRID:4201HUM-CCTCC00032, CCRID:5301HUM-KCB89023YJ, CCTCC:GDC0032, ChEMBL-Cells:CHEMBL3308499, ChEMBL-Targets:CHEMBL614181, CLS:300395, ECACC:97112601, FCS-free:179-2-338-1-16-3, GEO:GSM248209, GEO:GSM248210, GEO:GSM520665, GEO:GSM520666, GEO:GSM520667, GEO:GSM579888, GEO:GSM579889, GEO:GSM607969, GEO:GSM3738752, GEO:GSM3738753, IBRC:C10313, ICLC:HL95001, IZSLER:BS CL 68, JCRB:IFO50073, JCRB:JCRB9008, KCB:KCB 200412YJ, KCB:KCB 89023YJ, KCLB:10171, Lonza:52, NCBI_Iran:C125, PRIDE:PXD001909, PRIDE:PXD013120, PRIDE:PXD023286, PubChem_Cell_line:CVCL_0440, RCB:RCB0211, RCB:RCB0218, Wikidata:Q3273166 |
CVCL_0440 | 2026-08-01 05:23:40 | 2853 | |||
|
MRC-5 Resource Report Resource Website 1000+ mentions Discontinued |
IZSLER Cat# BS CL 68, RRID:CVCL_0440 | Homo sapiens (Human) | Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Senescence: Capable of attaining 42-46 population doublings before the onset of senescence (ATCC=CCL-171). Senesces at 26 PDL (PubMed=17395773)., Biotechnology: Used for the production of the live zoster vaccine (Trade name: Zostavax)., Biotechnology: Used for the production of the live varicella virus vaccine (Trade name: Varivax)., Biotechnology: Used for the production of the Hepatitis A vaccines Avaxim, Epaxal, Havrix and Vaqta., Biotechnology: Used for the production of the Human Diploid Cell Vaccine (HDCV) against rabies (Trade name: Imovax Rabies)., Group: Vaccine production cell line. |
PMID:113411 PMID:211143 PMID:932048 PMID:1031681 PMID:1193162 PMID:1756776 PMID:1965304 PMID:3335022 PMID:4316953 PMID:6538202 PMID:6971834 PMID:7065527 PMID:10752125 PMID:11416159 PMID:17395773 PMID:19657000 PMID:21637780 PMID:25877200 PMID:25903999 PMID:26477663 PMID:31869419 PMID:33389257 |
Finite cell line | Male | MRC5, MRC 5, MRCV, MRC-V, Medical Research Council cell strain-5 | IZSLER | BS CL 68 | BTO:BTO_0001590, CLO:CLO_0007865, CLO:CLO_0050055, EFO:EFO_0002835, MCCL:MCC:0000336, CLDB:cl3563, CLDB:cl3564, CLDB:cl3566, CLDB:cl3567, CLDB:cl3568, CLDB:cl5168, AddexBio:T0016002/4922, ATCC:CCL-171, BCRC:60023, BCRJ:0180, BioSample:SAMN01821580, BioSample:SAMN01821702, BioSample:SAMN01821735, BioSample:SAMN03473183, CCRID:1101HUM-PUMC000044, CCRID:1102HUM-NIFDC00002, CCRID:3101HUMGNHu41, CCRID:3101HUMSCSP5040, CCRID:4201HUM-CCTCC00032, CCRID:5301HUM-KCB89023YJ, CCTCC:GDC0032, ChEMBL-Cells:CHEMBL3308499, ChEMBL-Targets:CHEMBL614181, CLS:300395, ECACC:97112601, FCS-free:179-2-338-1-16-3, GEO:GSM248209, GEO:GSM248210, GEO:GSM520665, GEO:GSM520666, GEO:GSM520667, GEO:GSM579888, GEO:GSM579889, GEO:GSM607969, GEO:GSM3738752, GEO:GSM3738753, IBRC:C10313, ICLC:HL95001, IZSLER:BS CL 68, JCRB:IFO50073, JCRB:JCRB9008, KCB:KCB 200412YJ, KCB:KCB 89023YJ, KCLB:10171, Lonza:52, NCBI_Iran:C125, PRIDE:PXD001909, PRIDE:PXD013120, PRIDE:PXD023286, PubChem_Cell_line:CVCL_0440, RCB:RCB0211, RCB:RCB0218, Wikidata:Q3273166 |
CVCL_0440 | 2026-08-01 05:23:45 | 2853 | |||
|
MRC-5 Resource Report Resource Website 1000+ mentions Discontinued |
KCLB Cat# 10171, RRID:CVCL_0440 | Homo sapiens (Human) | Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Senescence: Capable of attaining 42-46 population doublings before the onset of senescence (ATCC=CCL-171). Senesces at 26 PDL (PubMed=17395773)., Biotechnology: Used for the production of the live zoster vaccine (Trade name: Zostavax)., Biotechnology: Used for the production of the live varicella virus vaccine (Trade name: Varivax)., Biotechnology: Used for the production of the Hepatitis A vaccines Avaxim, Epaxal, Havrix and Vaqta., Biotechnology: Used for the production of the Human Diploid Cell Vaccine (HDCV) against rabies (Trade name: Imovax Rabies)., Group: Vaccine production cell line. |
PMID:113411 PMID:211143 PMID:932048 PMID:1031681 PMID:1193162 PMID:1756776 PMID:1965304 PMID:3335022 PMID:4316953 PMID:6538202 PMID:6971834 PMID:7065527 PMID:10752125 PMID:11416159 PMID:17395773 PMID:19657000 PMID:21637780 PMID:25877200 PMID:25903999 PMID:26477663 PMID:31869419 PMID:33389257 |
Finite cell line | Male | MRC5, MRC 5, MRCV, MRC-V, Medical Research Council cell strain-5 | KCLB | 10171 | BTO:BTO_0001590, CLO:CLO_0007865, CLO:CLO_0050055, EFO:EFO_0002835, MCCL:MCC:0000336, CLDB:cl3563, CLDB:cl3564, CLDB:cl3566, CLDB:cl3567, CLDB:cl3568, CLDB:cl5168, AddexBio:T0016002/4922, ATCC:CCL-171, BCRC:60023, BCRJ:0180, BioSample:SAMN01821580, BioSample:SAMN01821702, BioSample:SAMN01821735, BioSample:SAMN03473183, CCRID:1101HUM-PUMC000044, CCRID:1102HUM-NIFDC00002, CCRID:3101HUMGNHu41, CCRID:3101HUMSCSP5040, CCRID:4201HUM-CCTCC00032, CCRID:5301HUM-KCB89023YJ, CCTCC:GDC0032, ChEMBL-Cells:CHEMBL3308499, ChEMBL-Targets:CHEMBL614181, CLS:300395, ECACC:97112601, FCS-free:179-2-338-1-16-3, GEO:GSM248209, GEO:GSM248210, GEO:GSM520665, GEO:GSM520666, GEO:GSM520667, GEO:GSM579888, GEO:GSM579889, GEO:GSM607969, GEO:GSM3738752, GEO:GSM3738753, IBRC:C10313, ICLC:HL95001, IZSLER:BS CL 68, JCRB:IFO50073, JCRB:JCRB9008, KCB:KCB 200412YJ, KCB:KCB 89023YJ, KCLB:10171, Lonza:52, NCBI_Iran:C125, PRIDE:PXD001909, PRIDE:PXD013120, PRIDE:PXD023286, PubChem_Cell_line:CVCL_0440, RCB:RCB0211, RCB:RCB0218, Wikidata:Q3273166 |
CVCL_0440 | 2026-08-01 05:23:40 | 2853 | |||
|
MRC-5 Resource Report Resource Website 1000+ mentions Discontinued |
ICLC Cat# HL95001, RRID:CVCL_0440 | Homo sapiens (Human) | Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Senescence: Capable of attaining 42-46 population doublings before the onset of senescence (ATCC=CCL-171). Senesces at 26 PDL (PubMed=17395773)., Biotechnology: Used for the production of the live zoster vaccine (Trade name: Zostavax)., Biotechnology: Used for the production of the live varicella virus vaccine (Trade name: Varivax)., Biotechnology: Used for the production of the Hepatitis A vaccines Avaxim, Epaxal, Havrix and Vaqta., Biotechnology: Used for the production of the Human Diploid Cell Vaccine (HDCV) against rabies (Trade name: Imovax Rabies)., Group: Vaccine production cell line. |
PMID:113411 PMID:211143 PMID:932048 PMID:1031681 PMID:1193162 PMID:1756776 PMID:1965304 PMID:3335022 PMID:4316953 PMID:6538202 PMID:6971834 PMID:7065527 PMID:10752125 PMID:11416159 PMID:17395773 PMID:19657000 PMID:21637780 PMID:25877200 PMID:25903999 PMID:26477663 PMID:31869419 PMID:33389257 |
Finite cell line | Male | MRC5, MRC 5, MRCV, MRC-V, Medical Research Council cell strain-5 | ICLC | HL95001 | BTO:BTO_0001590, CLO:CLO_0007865, CLO:CLO_0050055, EFO:EFO_0002835, MCCL:MCC:0000336, CLDB:cl3563, CLDB:cl3564, CLDB:cl3566, CLDB:cl3567, CLDB:cl3568, CLDB:cl5168, AddexBio:T0016002/4922, ATCC:CCL-171, BCRC:60023, BCRJ:0180, BioSample:SAMN01821580, BioSample:SAMN01821702, BioSample:SAMN01821735, BioSample:SAMN03473183, CCRID:1101HUM-PUMC000044, CCRID:1102HUM-NIFDC00002, CCRID:3101HUMGNHu41, CCRID:3101HUMSCSP5040, CCRID:4201HUM-CCTCC00032, CCRID:5301HUM-KCB89023YJ, CCTCC:GDC0032, ChEMBL-Cells:CHEMBL3308499, ChEMBL-Targets:CHEMBL614181, CLS:300395, ECACC:97112601, FCS-free:179-2-338-1-16-3, GEO:GSM248209, GEO:GSM248210, GEO:GSM520665, GEO:GSM520666, GEO:GSM520667, GEO:GSM579888, GEO:GSM579889, GEO:GSM607969, GEO:GSM3738752, GEO:GSM3738753, IBRC:C10313, ICLC:HL95001, IZSLER:BS CL 68, JCRB:IFO50073, JCRB:JCRB9008, KCB:KCB 200412YJ, KCB:KCB 89023YJ, KCLB:10171, Lonza:52, NCBI_Iran:C125, PRIDE:PXD001909, PRIDE:PXD013120, PRIDE:PXD023286, PubChem_Cell_line:CVCL_0440, RCB:RCB0211, RCB:RCB0218, Wikidata:Q3273166 |
CVCL_0440 | 2026-08-01 05:23:40 | 2853 | |||
|
MRC-5 Resource Report Resource Website 1000+ mentions Discontinued |
RCB Cat# RCB0211, RRID:CVCL_0440 | Homo sapiens (Human) | Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Senescence: Capable of attaining 42-46 population doublings before the onset of senescence (ATCC=CCL-171). Senesces at 26 PDL (PubMed=17395773)., Biotechnology: Used for the production of the live zoster vaccine (Trade name: Zostavax)., Biotechnology: Used for the production of the live varicella virus vaccine (Trade name: Varivax)., Biotechnology: Used for the production of the Hepatitis A vaccines Avaxim, Epaxal, Havrix and Vaqta., Biotechnology: Used for the production of the Human Diploid Cell Vaccine (HDCV) against rabies (Trade name: Imovax Rabies)., Group: Vaccine production cell line. |
PMID:113411 PMID:211143 PMID:932048 PMID:1031681 PMID:1193162 PMID:1756776 PMID:1965304 PMID:3335022 PMID:4316953 PMID:6538202 PMID:6971834 PMID:7065527 PMID:10752125 PMID:11416159 PMID:17395773 PMID:19657000 PMID:21637780 PMID:25877200 PMID:25903999 PMID:26477663 PMID:31869419 PMID:33389257 |
Finite cell line | Male | MRC5, MRC 5, MRCV, MRC-V, Medical Research Council cell strain-5 | RCB | RCB0211 | BTO:BTO_0001590, CLO:CLO_0007865, CLO:CLO_0050055, EFO:EFO_0002835, MCCL:MCC:0000336, CLDB:cl3563, CLDB:cl3564, CLDB:cl3566, CLDB:cl3567, CLDB:cl3568, CLDB:cl5168, AddexBio:T0016002/4922, ATCC:CCL-171, BCRC:60023, BCRJ:0180, BioSample:SAMN01821580, BioSample:SAMN01821702, BioSample:SAMN01821735, BioSample:SAMN03473183, CCRID:1101HUM-PUMC000044, CCRID:1102HUM-NIFDC00002, CCRID:3101HUMGNHu41, CCRID:3101HUMSCSP5040, CCRID:4201HUM-CCTCC00032, CCRID:5301HUM-KCB89023YJ, CCTCC:GDC0032, ChEMBL-Cells:CHEMBL3308499, ChEMBL-Targets:CHEMBL614181, CLS:300395, ECACC:97112601, FCS-free:179-2-338-1-16-3, GEO:GSM248209, GEO:GSM248210, GEO:GSM520665, GEO:GSM520666, GEO:GSM520667, GEO:GSM579888, GEO:GSM579889, GEO:GSM607969, GEO:GSM3738752, GEO:GSM3738753, IBRC:C10313, ICLC:HL95001, IZSLER:BS CL 68, JCRB:IFO50073, JCRB:JCRB9008, KCB:KCB 200412YJ, KCB:KCB 89023YJ, KCLB:10171, Lonza:52, NCBI_Iran:C125, PRIDE:PXD001909, PRIDE:PXD013120, PRIDE:PXD023286, PubChem_Cell_line:CVCL_0440, RCB:RCB0211, RCB:RCB0218, Wikidata:Q3273166 |
CVCL_0440 | 2026-08-01 05:23:45 | 2853 | |||
|
MRC-5 Resource Report Resource Website 1000+ mentions Discontinued |
BCRJ Cat# 0180, RRID:CVCL_0440 | Homo sapiens (Human) | Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Senescence: Capable of attaining 42-46 population doublings before the onset of senescence (ATCC=CCL-171). Senesces at 26 PDL (PubMed=17395773)., Biotechnology: Used for the production of the live zoster vaccine (Trade name: Zostavax)., Biotechnology: Used for the production of the live varicella virus vaccine (Trade name: Varivax)., Biotechnology: Used for the production of the Hepatitis A vaccines Avaxim, Epaxal, Havrix and Vaqta., Biotechnology: Used for the production of the Human Diploid Cell Vaccine (HDCV) against rabies (Trade name: Imovax Rabies)., Group: Vaccine production cell line. |
PMID:113411 PMID:211143 PMID:932048 PMID:1031681 PMID:1193162 PMID:1756776 PMID:1965304 PMID:3335022 PMID:4316953 PMID:6538202 PMID:6971834 PMID:7065527 PMID:10752125 PMID:11416159 PMID:17395773 PMID:19657000 PMID:21637780 PMID:25877200 PMID:25903999 PMID:26477663 PMID:31869419 PMID:33389257 |
Finite cell line | Male | MRC5, MRC 5, MRCV, MRC-V, Medical Research Council cell strain-5 | BCRJ | 0180 | BTO:BTO_0001590, CLO:CLO_0007865, CLO:CLO_0050055, EFO:EFO_0002835, MCCL:MCC:0000336, CLDB:cl3563, CLDB:cl3564, CLDB:cl3566, CLDB:cl3567, CLDB:cl3568, CLDB:cl5168, AddexBio:T0016002/4922, ATCC:CCL-171, BCRC:60023, BCRJ:0180, BioSample:SAMN01821580, BioSample:SAMN01821702, BioSample:SAMN01821735, BioSample:SAMN03473183, CCRID:1101HUM-PUMC000044, CCRID:1102HUM-NIFDC00002, CCRID:3101HUMGNHu41, CCRID:3101HUMSCSP5040, CCRID:4201HUM-CCTCC00032, CCRID:5301HUM-KCB89023YJ, CCTCC:GDC0032, ChEMBL-Cells:CHEMBL3308499, ChEMBL-Targets:CHEMBL614181, CLS:300395, ECACC:97112601, FCS-free:179-2-338-1-16-3, GEO:GSM248209, GEO:GSM248210, GEO:GSM520665, GEO:GSM520666, GEO:GSM520667, GEO:GSM579888, GEO:GSM579889, GEO:GSM607969, GEO:GSM3738752, GEO:GSM3738753, IBRC:C10313, ICLC:HL95001, IZSLER:BS CL 68, JCRB:IFO50073, JCRB:JCRB9008, KCB:KCB 200412YJ, KCB:KCB 89023YJ, KCLB:10171, Lonza:52, NCBI_Iran:C125, PRIDE:PXD001909, PRIDE:PXD013120, PRIDE:PXD023286, PubChem_Cell_line:CVCL_0440, RCB:RCB0211, RCB:RCB0218, Wikidata:Q3273166 |
CVCL_0440 | 2026-08-01 05:23:45 | 2853 | |||
|
MRC-5 Resource Report Resource Website 1000+ mentions Discontinued |
RCB Cat# RCB0218, RRID:CVCL_0440 | Homo sapiens (Human) | Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Senescence: Capable of attaining 42-46 population doublings before the onset of senescence (ATCC=CCL-171). Senesces at 26 PDL (PubMed=17395773)., Biotechnology: Used for the production of the live zoster vaccine (Trade name: Zostavax)., Biotechnology: Used for the production of the live varicella virus vaccine (Trade name: Varivax)., Biotechnology: Used for the production of the Hepatitis A vaccines Avaxim, Epaxal, Havrix and Vaqta., Biotechnology: Used for the production of the Human Diploid Cell Vaccine (HDCV) against rabies (Trade name: Imovax Rabies)., Group: Vaccine production cell line. |
PMID:113411 PMID:211143 PMID:932048 PMID:1031681 PMID:1193162 PMID:1756776 PMID:1965304 PMID:3335022 PMID:4316953 PMID:6538202 PMID:6971834 PMID:7065527 PMID:10752125 PMID:11416159 PMID:17395773 PMID:19657000 PMID:21637780 PMID:25877200 PMID:25903999 PMID:26477663 PMID:31869419 PMID:33389257 |
Finite cell line | Male | MRC5, MRC 5, MRCV, MRC-V, Medical Research Council cell strain-5 | RCB | RCB0218 | BTO:BTO_0001590, CLO:CLO_0007865, CLO:CLO_0050055, EFO:EFO_0002835, MCCL:MCC:0000336, CLDB:cl3563, CLDB:cl3564, CLDB:cl3566, CLDB:cl3567, CLDB:cl3568, CLDB:cl5168, AddexBio:T0016002/4922, ATCC:CCL-171, BCRC:60023, BCRJ:0180, BioSample:SAMN01821580, BioSample:SAMN01821702, BioSample:SAMN01821735, BioSample:SAMN03473183, CCRID:1101HUM-PUMC000044, CCRID:1102HUM-NIFDC00002, CCRID:3101HUMGNHu41, CCRID:3101HUMSCSP5040, CCRID:4201HUM-CCTCC00032, CCRID:5301HUM-KCB89023YJ, CCTCC:GDC0032, ChEMBL-Cells:CHEMBL3308499, ChEMBL-Targets:CHEMBL614181, CLS:300395, ECACC:97112601, FCS-free:179-2-338-1-16-3, GEO:GSM248209, GEO:GSM248210, GEO:GSM520665, GEO:GSM520666, GEO:GSM520667, GEO:GSM579888, GEO:GSM579889, GEO:GSM607969, GEO:GSM3738752, GEO:GSM3738753, IBRC:C10313, ICLC:HL95001, IZSLER:BS CL 68, JCRB:IFO50073, JCRB:JCRB9008, KCB:KCB 200412YJ, KCB:KCB 89023YJ, KCLB:10171, Lonza:52, NCBI_Iran:C125, PRIDE:PXD001909, PRIDE:PXD013120, PRIDE:PXD023286, PubChem_Cell_line:CVCL_0440, RCB:RCB0211, RCB:RCB0218, Wikidata:Q3273166 |
CVCL_0440 | 2026-08-01 05:23:40 | 2853 | |||
|
MRC-5 Resource Report Resource Website 1000+ mentions Discontinued |
BCRC Cat# 60023, RRID:CVCL_0440 | Homo sapiens (Human) | Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Senescence: Capable of attaining 42-46 population doublings before the onset of senescence (ATCC=CCL-171). Senesces at 26 PDL (PubMed=17395773)., Biotechnology: Used for the production of the live zoster vaccine (Trade name: Zostavax)., Biotechnology: Used for the production of the live varicella virus vaccine (Trade name: Varivax)., Biotechnology: Used for the production of the Hepatitis A vaccines Avaxim, Epaxal, Havrix and Vaqta., Biotechnology: Used for the production of the Human Diploid Cell Vaccine (HDCV) against rabies (Trade name: Imovax Rabies)., Group: Vaccine production cell line. |
PMID:113411 PMID:211143 PMID:932048 PMID:1031681 PMID:1193162 PMID:1756776 PMID:1965304 PMID:3335022 PMID:4316953 PMID:6538202 PMID:6971834 PMID:7065527 PMID:10752125 PMID:11416159 PMID:17395773 PMID:19657000 PMID:21637780 PMID:25877200 PMID:25903999 PMID:26477663 PMID:31869419 PMID:33389257 |
Finite cell line | Male | MRC5, MRC 5, MRCV, MRC-V, Medical Research Council cell strain-5 | BCRC | 60023 | BTO:BTO_0001590, CLO:CLO_0007865, CLO:CLO_0050055, EFO:EFO_0002835, MCCL:MCC:0000336, CLDB:cl3563, CLDB:cl3564, CLDB:cl3566, CLDB:cl3567, CLDB:cl3568, CLDB:cl5168, AddexBio:T0016002/4922, ATCC:CCL-171, BCRC:60023, BCRJ:0180, BioSample:SAMN01821580, BioSample:SAMN01821702, BioSample:SAMN01821735, BioSample:SAMN03473183, CCRID:1101HUM-PUMC000044, CCRID:1102HUM-NIFDC00002, CCRID:3101HUMGNHu41, CCRID:3101HUMSCSP5040, CCRID:4201HUM-CCTCC00032, CCRID:5301HUM-KCB89023YJ, CCTCC:GDC0032, ChEMBL-Cells:CHEMBL3308499, ChEMBL-Targets:CHEMBL614181, CLS:300395, ECACC:97112601, FCS-free:179-2-338-1-16-3, GEO:GSM248209, GEO:GSM248210, GEO:GSM520665, GEO:GSM520666, GEO:GSM520667, GEO:GSM579888, GEO:GSM579889, GEO:GSM607969, GEO:GSM3738752, GEO:GSM3738753, IBRC:C10313, ICLC:HL95001, IZSLER:BS CL 68, JCRB:IFO50073, JCRB:JCRB9008, KCB:KCB 200412YJ, KCB:KCB 89023YJ, KCLB:10171, Lonza:52, NCBI_Iran:C125, PRIDE:PXD001909, PRIDE:PXD013120, PRIDE:PXD023286, PubChem_Cell_line:CVCL_0440, RCB:RCB0211, RCB:RCB0218, Wikidata:Q3273166 |
CVCL_0440 | 2026-08-01 05:23:45 | 2853 | |||
|
MRC-5 Resource Report Resource Website 1000+ mentions Discontinued |
CLS Cat# 300395, RRID:CVCL_0440 | Homo sapiens (Human) | Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Senescence: Capable of attaining 42-46 population doublings before the onset of senescence (ATCC=CCL-171). Senesces at 26 PDL (PubMed=17395773)., Biotechnology: Used for the production of the live zoster vaccine (Trade name: Zostavax)., Biotechnology: Used for the production of the live varicella virus vaccine (Trade name: Varivax)., Biotechnology: Used for the production of the Hepatitis A vaccines Avaxim, Epaxal, Havrix and Vaqta., Biotechnology: Used for the production of the Human Diploid Cell Vaccine (HDCV) against rabies (Trade name: Imovax Rabies)., Group: Vaccine production cell line. |
PMID:113411 PMID:211143 PMID:932048 PMID:1031681 PMID:1193162 PMID:1756776 PMID:1965304 PMID:3335022 PMID:4316953 PMID:6538202 PMID:6971834 PMID:7065527 PMID:10752125 PMID:11416159 PMID:17395773 PMID:19657000 PMID:21637780 PMID:25877200 PMID:25903999 PMID:26477663 PMID:31869419 PMID:33389257 |
Finite cell line | Male | MRC5, MRC 5, MRCV, MRC-V, Medical Research Council cell strain-5 | CLS | 300395 | BTO:BTO_0001590, CLO:CLO_0007865, CLO:CLO_0050055, EFO:EFO_0002835, MCCL:MCC:0000336, CLDB:cl3563, CLDB:cl3564, CLDB:cl3566, CLDB:cl3567, CLDB:cl3568, CLDB:cl5168, AddexBio:T0016002/4922, ATCC:CCL-171, BCRC:60023, BCRJ:0180, BioSample:SAMN01821580, BioSample:SAMN01821702, BioSample:SAMN01821735, BioSample:SAMN03473183, CCRID:1101HUM-PUMC000044, CCRID:1102HUM-NIFDC00002, CCRID:3101HUMGNHu41, CCRID:3101HUMSCSP5040, CCRID:4201HUM-CCTCC00032, CCRID:5301HUM-KCB89023YJ, CCTCC:GDC0032, ChEMBL-Cells:CHEMBL3308499, ChEMBL-Targets:CHEMBL614181, CLS:300395, ECACC:97112601, FCS-free:179-2-338-1-16-3, GEO:GSM248209, GEO:GSM248210, GEO:GSM520665, GEO:GSM520666, GEO:GSM520667, GEO:GSM579888, GEO:GSM579889, GEO:GSM607969, GEO:GSM3738752, GEO:GSM3738753, IBRC:C10313, ICLC:HL95001, IZSLER:BS CL 68, JCRB:IFO50073, JCRB:JCRB9008, KCB:KCB 200412YJ, KCB:KCB 89023YJ, KCLB:10171, Lonza:52, NCBI_Iran:C125, PRIDE:PXD001909, PRIDE:PXD013120, PRIDE:PXD023286, PubChem_Cell_line:CVCL_0440, RCB:RCB0211, RCB:RCB0218, Wikidata:Q3273166 |
CVCL_0440 | 2026-08-01 05:42:19 | 2853 |
Can't find your Cell Line?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. If you want to find a specific cell line, it's easier to enter an RRID or add the vendor information to search. You can refine the search results using Facets on the left side of the search results page. If you are on the table view, you can also search in a specific column by clicking the column title and enter the keywords.
If you still could not find your cell line in the search results, please help us by registering it into the system — it's easy. Register it with the Cellosaurus. An RRID will be generated in 1-2 business days.
Welcome to the NIF Resources search. From here you can search through a compilation of resources used by NIF and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that NIF has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on NIF then you can log in from here to get additional features in NIF such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into NIF you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.
Welcome to the Neuroscience Information Framework Project, designed to serve the biomedical research community. NIF maintains the largest searchable collection of neuroscience data, the largest catalog of biomedical resources, and the largest ontology for neuroscience on the web. We welcome all feedback and suggestions and are actively looking for resource providers to make their resources accessible through NIF. Learn about the tools available to help you share your data and discover a dynamic inventory of Web-based neuroscience resources.
